Jeffrey Chamberlain, PhD
Affiliations: | University of Washington, Seattle, Seattle, WA |
Area:
muscle gene therapy, DMDGoogle:
"Jeffrey Chamberlain"Parents
Sign in to add mentor| Stephen D. Hauschka | grad student | University of Washington (Cell Biology Tree) | |
| C. Thomas Caskey | post-doc | Baylor College of Medicine (Neurotree) |
Children
Sign in to add trainee| Gregory E Crawford | grad student | (Computational Biology Tree) | |
| Daniel E. Michele | grad student | 2000 | University of Michigan |
| Christiana DelloRusso | grad student | 2002 | University of Michigan |
| Scott Q. Harper | grad student | 1997-2002 | University of Michigan |
| Dennis J. Hartigan-O'Connor | grad student | 2003 | University of Michigan |
| Michael J. Blankinship | grad student | 2005 | University of Michigan |
| Luke M. Judge | grad student | 2006 | University of Washington |
| Brian R. Schultz | grad student | 2009 | University of Washington |
| Andrea L. Arnett | grad student | 2011 | University of Washington |
| Lindsey A. Muir | grad student | 2012 | University of Washington |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Tasfaout H, Halbert CL, McMillen TS, et al. (2024) Split intein-mediated protein trans-splicing to express large dystrophins. Nature |
| Krishna S, Piepho AB, Lake DM, et al. (2024) Gene therapy delivered micro-dystrophins co-localize with transgenic utrophin in dystrophic skeletal muscle fibers. Neuromuscular Disorders : Nmd. 36: 1-5 |
| Szwec S, Kapłucha Z, Chamberlain JS, et al. (2023) Dystrophin- and Utrophin-Based Therapeutic Approaches for Treatment of Duchenne Muscular Dystrophy: A Comparative Review. Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy. 38: 95-119 |
| Lorena MDSV, Santos EKD, Ferretti R, et al. (2023) Biomarkers for Duchenne muscular dystrophy progression: impact of age in the mdx tongue spared muscle. Skeletal Muscle. 13: 16 |
| Hindi SM, Petrany MJ, Greenfeld E, et al. (2023) Enveloped viruses pseudotyped with mammalian myogenic cell fusogens target skeletal muscle for gene delivery. Cell. 186: 3520 |
| Lorena MDSV, Santos EK, Ferretti R, et al. (2023) Biomarkers for Duchenne muscular dystrophy progression: impact of age in the mdx tongue spared muscle. Research Square |
| Benasutti H, Maricelli JW, Seto J, et al. (2023) Efficacy and muscle safety assessment of fukutin-related protein gene therapy. Molecular Therapy. Methods & Clinical Development. 30: 65-80 |
| Hindi SM, Petrany MJ, Greenfeld E, et al. (2023) Enveloped viruses pseudotyped with mammalian myogenic cell fusogens target skeletal muscle for gene delivery. Cell |
| Cikes D, Elsayad K, Sezgin E, et al. (2023) Author Correction: PCYT2-regulated lipid biosynthesis is critical to muscle health and ageing. Nature Metabolism |
| Hindi SM, Petrany MJ, Greenfeld E, et al. (2023) Enveloped viruses pseudotyped with mammalian myogenic cell fusogens target skeletal muscle for gene delivery. Biorxiv : the Preprint Server For Biology |